You just read:

Immune Therapeutics, Inc., Through Its Wholly Owned Subsidiary TNI BioTech International, Ltd., Initiates Clinical Trial In Malawi With LDN For The Prevention Of Cervical Cancer

News provided by

Immune Therapeutics, Inc.

Aug 23, 2016, 13:00 ET